Cytokinetics eps
WebCytokines are produced by a broad range of cells, including immune cells like macrophages, B lymphocytes, T lymphocytes and mast cells, as well as endothelial cells, fibroblasts, … WebMar 31, 2024 · Cytokinetics develops first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised. Careers; Contact Us; Our Focus. We are developing …
Cytokinetics eps
Did you know?
WebFeb 24, 2024 · Cytokinetics (CYTK) delivered earnings and revenue surprises of 59.55% and 931.54%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock? WebApr 10, 2024 · Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and …
WebCytokinetics is headquartered in South San Francisco, California, the US. Headquarters United States of America Address ., 280 East Grand Avenue, South San Francisco, California, 94080 Website cytokinetics.com Telephone 1 650 6243000 No of Employees 253 Industry Pharmaceuticals and Healthcare Ticker Symbol & Exchange CYTK (NASD) WebFeb 24, 2024 · Cytokinetics press release (NASDAQ: CYTK): Q4 GAAP EPS of -$0.36 beats by $0.51. Revenue of $55.6M (+727.4% Y/Y) beats by $50.04M. Cash, cash equivalents and investments totaled $623.7 million...
WebApr 12, 2024 · Cytokinetics, Incorporated has a 1 year low of $32.96 and a 1 year high of $55.80. Cytokinetics ( NASDAQ:CYTK – Get Rating) last posted its earnings results on Wednesday, March 1st. The...
WebSOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on March 31, 2024 it granted stock options to purchase an aggregate of 57,600 shares of common stock to 4 new employees, whose employment commenced in March 2024, as a material inducement to their …
WebCytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with... sonia gandhi bornWebCytokinetics, Inc. operates as a biopharmaceutical company, which focuses on the discovery and development of muscle activators as potential treatment for debilitating diseases. sonia gandhi total net worthWebDiluted EPS (ttm)-4.33. Dividends Per Share. N/A. Dividend Yield. N/A. Ex-Dividend Date. N/A. ... Cytokinetics, a biotechnology company, had hoped that by focusing on improving the function of ... sonia gandhi investment in ambaniWebFeb 22, 2024 · This biopharmaceutical company is expected to post quarterly loss of $1.22 per share in its upcoming report, which represents a year-over-year change of -238.9%. Revenues are expected to be $7.46... soniagarnerfineartWebFlu-like symptoms (chills, fever, headache, fatigue, loss of appetite, nausea, vomiting) Low white blood cell counts (which increase the risk of infection) Skin rashes. … sonia gandhi latest photosWebAug 3, 2024 · Cytokinetics (CYTK) is scheduled to announce Q2 earnings results on Thursday, August 4th, after market close.The consensus EPS Estimate is -$1.01 and the consensus Revenue Estimate... sonia gandhi italian familyWebApr 10, 2024 · The company is expected to report EPS of $2.50, down 6.37% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $23.56 billion, up 0.59% from ... small heart shaped jewelry box